ZEJULA

all catalysts(0)

nothing on the calendar yet

News(5)

• Earnings roundup: Biogen’s ‘resiliency,’ AstraZeneca’s growth pitch and GSK’s oncology push
  Better-than-expected sales helped Biogen regain the support of investors, while AstraZeneca and GSK worked to convince Wall Street that they can hit ambitious revenue targets.
  biopharma_dive · 16d ago
• GSK lung cancer drug gets speedy approval following $10.6B deal
  The clearance is GSK’s first for a lung cancer medicine and the latest step forward in a yearslong push by the British drugmaker into oncology.
  biopharma_dive · 23d ago
• GSK, Hansoh ADC extends survival in lung cancer study
  GSK claimed the result was a first for an ADC aimed at the “B7-H3” protein, an increasingly popular target of late among cancer drugmakers.
  biopharma_dive · 1mo ago
• GSK boosts cancer pipeline with $11B Nuvalent buyout
  The British drugmaker's third acquisition this year gives it two experimental lung cancer drugs under FDA review that it hopes will support a franchise.
  biopharma_dive · 2mo ago
• GU Cancer Experts Highlight Top Abstracts to Watch During ASCO 2026
  We spoke with leading voices in GU oncology to see which presentations they are most looking forward to during the 2026 ASCO Annual Meeting.
  onclive · 3mo ago